Skip to main content
OpenTrials

Clinical trial condition

Hunter Syndrome

Explore clinical trials studying Hunter Syndrome. Study availability and eligibility vary by location and protocol.

21 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Hunter Syndrome trial results

Completed

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

NCT02055118

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Women's and Children's Hospital, 72 King William Road North Adelaide, Australia
View Trial Details
Completed

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

NCT00630747

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +24 more
Locations
  • St. Joseph's Hospital Phoenix, Arizona, United States
  • Pediatric Clinical Research Center, Children's Hospital Oakland Oakland, California, United States
  • The Children's Hospital Denver, Colorado, United States
  • Harbin Clinic Rome, Georgia, United States
View all 52 locations
View Trial Details
Completed

Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome

NCT01449240

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • Emory University Decatur, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States
  • University of North Carolina, Division of Genetics and Metabolism Chapel Hill, North Carolina, United States
View Trial Details
Completed

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

NCT00607386

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +24 more
Locations
  • Hospital de Clinicas de Porto Alegre, Servico de Genetica Medica Porto Alegre, Rio Grande do Sul, Brazil
  • Instytut Pomnik Centrum Zdrowia Dziecka, Klinika Chorob Metaboliczynch, Endokrynologii i Diabetologii Warsaw, Poland
  • National Taiwan University Hospital, Dept. of Pediatrics and Medical Genetics Taipei, Taiwan
View Trial Details
Completed

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

NCT00882921

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Children's Hospitals and Clinics of Minnesota, Division of Genetics Minneapolis, Minnesota, United States
  • Hospital de Clinicas de Porto Alegre, Servico de Genetica Medica Porto Alegre, Rio Grande do Sul, Brazil
  • Birmingham Children's Hospital Birmingham, United Kingdom
View Trial Details
Completed

Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

NCT01822184

Conditions
Carbohydrate Metabolism, Inborn Errors, Cognition Disorders, Cognitive Dysfunction, +25 more
Locations
  • Childrens Hospital & Research Center Oakland Oakland, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina Division of Genetics and Metabolism Chapel Hill, North Carolina, United States
  • Hospital Universitario Austral Pilar, Buenos Aires, Argentina
View Trial Details
Completed

Safety and Efficacy of Hunterase

NCT01645189

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • Samsug Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment

NCT06031259

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • M.A.G.I.C. Clinic Calgary, Alberta, Canada
  • University of British Columbia Vancouver, British Columbia, Canada
  • Hospital for Sick Children Toronto, Ontario, Canada
  • Hopital Femme Mere Enfant Bron, Auvergne-Rhône-Alpes, France
View Trial Details

Related conditions